Therese Bittermann, MD, MSCE
Assistant Professor of Medicine (Gastroenterology) at the Hospital of the University of Pennsylvania
Department: Medicine
Contact information
Hospital of the University of Pennsylvania
Penn Transplant Institute
2 Dulles
3400 Spruce Street
Philadelphia, PA 19104
Penn Transplant Institute
2 Dulles
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-349-8222
Fax: 215-349-5915
Fax: 215-349-5915
Education:
BA (Biological Sciences; International Studies)
Northwestern University, 2005.
MS (Physiology and Biophysics)
Georgetown University, 2006.
MD (Medicine)
Drexel University College of Medicine, 2010.
MS (Clinical Epidemiology)
University of Pennsylvania, 2017.
Permanent linkBA (Biological Sciences; International Studies)
Northwestern University, 2005.
MS (Physiology and Biophysics)
Georgetown University, 2006.
MD (Medicine)
Drexel University College of Medicine, 2010.
MS (Clinical Epidemiology)
University of Pennsylvania, 2017.
Description of Clinical Expertise
I care for patients with viral hepatitis, auto-immune diseases of the liver, fatty liver disease, liver tumors, and cirrhosis. I also have expertise in pre- and post-transplantation management.Description of Research Expertise
I study the relationship between immunosuppression strategy and outcomes after liver transplantation. I have previous expertise in research related to organ allocation, living donor liver transplantation, the effects of transplant policy-making, disparities in liver care and center variability in patient care. These efforts have spanned adult and pediatric transplant populations. I also have research interests in autoimmune hepatitis and alcohol-associated liver disease. I have an advanced degree in clinical epidemiology, and have expertise with observational study designs, large databases and statistics.Selected Publications
Durkin C, Schaubel DE, Kaplan DE, Mahmud N, Bittermann T: Survival Benefit From Corticosteroids in Severe Alcohol-associated Hepatitis Attributed to Clinical and Treatment Differences in a Large Multicenter Cohort Clinical and Translational Gastroenterology Epub ahead of print, Dec 2024.Bittermann T, Schaubel DE: Obeticholic acid as second-line therapy for primary biliary cholangitis: Does target trial emulation solve the issue? Hepatology Epub ahead of print, Dec 2024.
Ibeabuchi T, Li E, Cywes C, Bittermann T, Mahmud N, Abt PL: The Association Between the Origin of the Donation After Circulatory Death Liver Recovery Team and Graft Survival: A National Study Transplantation Direct 10(10), Sept 2024.
Rosenthal BE, Schaubel DE, Lewis JD, Margolis DJ, Goldberg DS, Bittermann T: Immunosuppression regimen and latitude impact keratinocyte carcinoma risk in U.S. liver transplant recipients Archives Dermatological Research 316(9), Sept 2024.
Bittermann T, Kathawate RG, Schaubel DE, Lewis JD, Goldberg DS: Hospital readmission for acute kidney injury is independently associated with de novo end-stage renal disease after liver transplantation. Liver Transplantation Epub ahead of print, Aug 2024.
Barr LG, Abt P, Rand EB, Bittermann T: Waitlist outcomes of pediatric liver transplant recipients relisted as adults. Liver Transplantation Epub ahead of print, Aug 2024.
Rosenstengle C, Serper M, Asrani SK, Bittermann T, Du J, Ma TW, Goldberg D, Gines P, Kamath PS: Variation in intention-to-treat survival by MELD subtypes: all models created for end-stage liver disease are not equal. Journal of Hepatology Epub ahead of print, Aug 2024.
Kulkarni AV, Wall A, Reddy KR, Bittermann T: Early living donor liver transplantation for alcohol-associated hepatitis: Status in the era of increasing demand, unmet needs, and future considerations Liver Transplantation Epub ahead of print, Jul 2024.
Goswami A, Weinberg E, Coraluzzi L, Bittermann T, Nahas J, Addis S, Weinrieb R, Serper M: A Tailored Virtual Program for Alcohol Use Disorder Treatment Among Liver Transplant Candidates and Recipients Is Feasible and Associated With Lower Post-Transplant Relapse Clinical Transplantation 38(7): e15381, Jul 2024.
Bittermann T, Byhoff E: CON: Satellite clinics are a marketing tool and do not improve access and equity in liver transplantation. Liver Transplantation Epub ahead of print, Jul 2024.